Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,365 studies match

clinicaltrialsPublishedShowing 551–600 of 1,365 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04052997	Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma	completed	Phase 2	117	ADC Therapeutics S.A.INDUSTRY	11	Mar 28, 2024	clinicaltrials
NCT04113616	An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)	terminated	Phase 1 / Phase 2	70	Kartos Therapeutics, Inc.INDUSTRY